astragaloside a has been researched along with Neoplasm Metastasis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, S; Jin, L; Zheng, W | 1 |
| Cui, J; Cui, WQ; Dong, JC; Gong, WY; Hu, LL; Liu, BJ; Qiu, J; Wei, Y; Xu, F | 1 |
| Cheng, X; Gu, J; Jia, X; Jiang, J; Yuan, J; Zhang, M; Zhao, B | 1 |
3 other study(ies) available for astragaloside a and Neoplasm Metastasis
| Article | Year |
|---|---|
Astragaloside IV inhibits cell proliferation and metastasis of breast cancer via promoting the long noncoding RNA TRHDE-AS1.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; Male; Mice; Mice, Nude; Neoplasm Metastasis; RNA, Long Noncoding; Saponins; Transfection; Triterpenes | 2021 |
Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling.
Topics: A549 Cells; AMP-Activated Protein Kinase Kinases; Cell Polarity; Disease Progression; Gene Expression Regulation, Neoplastic; Humans; Interleukin-13; Lung Neoplasms; Macrophages; Neoplasm Metastasis; Protein Kinases; Saponins; Signal Transduction; Triterpenes; Vesicular Transport Proteins | 2018 |
Astragaloside IV inhibits migration and invasion in human lung cancer A549 cells via regulating PKC-α-ERK1/2-NF-κB pathway.
Topics: Astragalus propinquus; Biomarkers, Tumor; Cell Line, Tumor; Cell Movement; Cytokines; Drugs, Chinese Herbal; Extracellular Matrix Proteins; Humans; Inflammation Mediators; Lung Neoplasms; MAP Kinase Signaling System; Neoplasm Invasiveness; Neoplasm Metastasis; NF-kappa B; Protein Kinase C; Saponins; Triterpenes | 2014 |